Imaging the norepinephrine transporter in humans with (S,S)-[11C]O-methyl reboxetine and PET: problems and progress
Authors:
- 1 August 2007
- journal article
- clinical trial
- Published by Elsevier in Nuclear Medicine and Biology
- Vol. 34 (6) , 667-679
Abstract
No abstract availableKeywords
This publication has 39 references indexed in Scilit:
- AN INTEGRATIVE THEORY OF LOCUS COERULEUS-NOREPINEPHRINE FUNCTION: Adaptive Gain and Optimal PerformanceAnnual Review of Neuroscience, 2005
- Depression in Parkinson's disease: loss of dopamine and noradrenaline innervation in the limbic systemBrain, 2005
- The Role of Norepinephrine in the Behavioral and Psychological Symptoms of DementiaThe Journal of Neuropsychiatry and Clinical Neurosciences, 2004
- Potentiation of parkinsonian symptoms by depletion of locus coeruleus noradrenaline in 6‐hydroxydopamine‐induced partial degeneration of substantia nigra in ratsEuropean Journal of Neuroscience, 2003
- Atomoxetine Increases Extracellular Levels of Norepinephrine and Dopamine in Prefrontal Cortex of Rat A Potential Mechanism for Efficacy in Attention Deficit/Hyperactivity DisorderNeuropsychopharmacology, 2002
- Chronic and acute regulation of Na+/Cl–-dependent neurotransmitter transporters: drugs, substrates, presynaptic receptors, and signaling systemsPharmacology & Therapeutics, 2001
- Reduced Levels of Norepinephrine Transporters in the Locus Coeruleus in Major DepressionJournal of Neuroscience, 1997
- Locus coeruleus neurons in monkey are selectively activated by attended cues in a vigilance taskThe Journal of Neuroscience, 1994
- Reduction of cortical dopamine, noradrenaline, serotonin and their metabolites in Parkinson's diseaseBrain Research, 1983
- Brain-noradrenaline and 3-methoxy-4-hydroxyphenylglycol in Parkinson's syndromeJournal of Neural Transmission, 1977